Cessation of screening for intestinal carriage of extended-spectrum β-lactamase- producing Enterobacteriaceae in a low-endemicity intensive care unit with.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors  S. Amit, H. Mishali, T. Kotlovsky,
Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study  E. Munier-Marion, T. Bénet, C. Régis,
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study  E. Munier-Marion, T. Bénet, C. Régis,
Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia  F.P. Paling, M. Wolkewitz, L.G.M. Bode, P.M.C.
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
E. S. Björnsdóttir, E. R. Martins, H. Erlendsdóttir, G. Haraldsson, J
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
M. R. Haverkate, T. N. Platteel, A. C. Fluit, J. W. Cohen Stuart, M. A
Migrant health—a cause for concern?
Evolution of extended-spectrum β-lactamases by mutation
Defining an extended-spectrum β-lactamase
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis  G. Choudhury,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
J.-P. Van geertruyden  Clinical Microbiology and Infection 
The microarray technology: facts and controversies
Evaluation of VITEK 2 for analysis of Enterobacteriaceae using the Advanced Expert System (AES) versus interpretive susceptibility guidelines used at.
Refugee crisis and re-emergence of forgotten infections in Europe
Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance—a retrospective population based study.
R. Cantón  Clinical Microbiology and Infection 
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
Extended-spectrum β-lactamase/AmpC- and carbapenemase-producing Enterobacteriaceae in animals: a threat for humans?  J.-Y. Madec, M. Haenni, P. Nordmann,
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012  V.
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit  K. Thorburn,
Trends in length of stay, mortality and readmission among patients with community- acquired bacteraemia  M. Søgaard, R.W. Thomsen, R.B. Bang, H.C. Schønheyder,
Travel to Asia and traveller's diarrhoea with antibiotic treatment are independent risk factors for acquiring ciprofloxacin-resistant and extended spectrum.
Vector control: a cornerstone in the malaria elimination campaign
Effects of gentamicin monotherapy for the initial treatment of community-onset complicated non-obstructive acute pyelonephritis due to Enterobacteriaceae.
Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community  R.E. Warren, G. Harvey, R. Carr, D. Ward,
Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit  E. Theocharidou, B. Agarwal, G. Jeffrey,
Regional distribution of nosocomial infections due to ESBL-positive Enterobacteriaceae in Germany: data from the German National Reference Center for.
Four-year epidemiological study of extended-spectrum β-lactamase-producing Enterobacteriaceae in a French teaching hospital  L. Gibold, F. Robin, R.-N.
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose  P. Savard, T.M. Perl  Clinical Microbiology.
Metagenomics and probiotics
Risk factors for extended-spectrum β-lactamase-producing Escherichia coli urinary tract infection in the community in Denmark: a case–control study  M.
Faecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae is common 12 months after infection and is related to strain factors  E.
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Prevalence and diversity of extended-spectrum ß-lactamases in faecal Escherichia coli isolates from healthy humans in Spain  L. Vinué, Y. Sáenz, S. Martínez,
S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K
Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit  S. Nseir, C. Blazejewski, R. Lubret,
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
R. Cantón, A. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, T
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
New oral cephalosporins in pediatric community-acquired infections
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
Are we losing the fight against malaria one more time?
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
Impact of a targeted isolation strategy at intensive-care-unit-admission on intensive- care-unit-acquired infection related to multidrug-resistant bacteria:
Staphylococcus aureus colonization at ICU admission as a risk factor for developing S. aureus ICU pneumonia  F.P. Paling, M. Wolkewitz, L.G.M. Bode, P.M.C.
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Cessation of screening for intestinal carriage of extended-spectrum β-lactamase- producing Enterobacteriaceae in a low-endemicity intensive care unit with universal contact precautions  W. Jalalzaï, M. Boutrot, J. Guinard, A. Guigon, L. Bret, D.-M. Poisson, T. Boulain, F. Barbier  Clinical Microbiology and Infection  Volume 24, Issue 4, Pages 429.e7-429.e12 (April 2018) DOI: 10.1016/j.cmi.2017.08.005 Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Cumulative incidence of intensive care unit (ICU) -acquired extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) infections, in-ICU deaths and ICU discharges in periods with and without active surveillance culture (ASC) for the detection of ESBL-E carriage. (a) Cumulative incidence of ICU-acquired ESBL-E infections in periods with and without ASC as compared using a Fine and Gray model with in-ICU death or ICU discharge considered as competing events; (b) Cumulative incidence of in-ICU death in periods with and without ASC compared using a Fine and Gray model adjusted on the Simplified Acute Physiology Score II value at ICU admission and with ICU discharge considered as a competing event. Clinical Microbiology and Infection 2018 24, 429.e7-429.e12DOI: (10.1016/j.cmi.2017.08.005) Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions